Heart Failure Management Devices - (Effective Date - 2026-06-15) 7.01.91
Effective June 15, 2026, heart failure management devices in the outpatient setting are considered investigational, including carotid baroreflex activation therapy (e.g., Barostim device), cardiac pressure sensor devices (e.g., CardioMEMS HF system and V-Lap), cardiac contractility modulation (CCM) devices (e.g., Optimizer Smart), and combined CCM with ICD devices (CCM-D) (e.g., Optimizer Integra CCM-D System). The February 19, 2026 annual review revised the policy statement to add baroreflex activation therapy devices as investigational, added a policy statement for CCM devices, added codes 0408T-0409T, 0915T-0916T and 0923T, and added code 64654 to replace code 0266T.